| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/22/2003 | EP1276766A2 G protein-coupled receptors |
| 01/22/2003 | EP1276765A2 Single-chain fertility hormones with variable lh activity |
| 01/22/2003 | EP1276764A1 Human polynucleotides, polypeptides, and antibodies |
| 01/22/2003 | EP1276763A1 Anti-freeze proteins, their production and use |
| 01/22/2003 | EP1276762A1 Porphyromonas gingivalis recombinant proteins and truncations |
| 01/22/2003 | EP1276761A2 New bromodomain protein |
| 01/22/2003 | EP1276760A2 Polyamide nucleic acid derivatives, agents and methods for producing them |
| 01/22/2003 | EP1276757A1 ANTIGENIC PEPTIDE FRAGMENTS OF VapA PROTEIN, AND USES THEREOF |
| 01/22/2003 | EP1276755A1 Novel compounds |
| 01/22/2003 | EP1276754A2 Materials and methods relating to lipid metabolism |
| 01/22/2003 | EP1276751A2 Novel nucleic acids and polypeptides |
| 01/22/2003 | EP1276493A2 Cxcr4 agonist treatment of hematopoietic cells |
| 01/22/2003 | EP1276492A2 P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof |
| 01/22/2003 | EP1276490A1 Novel borrelia burgdorferi polypeptides and uses thereof |
| 01/22/2003 | EP1276371A2 Transgenic animal |
| 01/22/2003 | EP1228090A4 Novel molecules and the card-related protein family and uses thereof |
| 01/22/2003 | EP1222459A4 Crystallographic structure of the androgen receptor ligand binding domain |
| 01/22/2003 | EP1107980B1 CRYSTALLINE FORMS OF EtO2C-CH2-(R)Cgl-Aze-Pab-OH |
| 01/22/2003 | EP1017405A4 Therapeutic hemoglobin composition having isotropically increased size |
| 01/22/2003 | EP0973901B1 Flip gene and flip protein |
| 01/22/2003 | EP0873423A4 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
| 01/22/2003 | EP0832199A4 Fucosyltransferase genes and uses thereof |
| 01/22/2003 | EP0635028B1 Pulmonary surfactant protein fragments |
| 01/22/2003 | EP0627004B1 Improvements in or relating to malaria vaccine |
| 01/22/2003 | EP0610436B1 Hepatitis-c virus testing |
| 01/22/2003 | EP0540651B1 Endogenously sweetened transgenic plant products |
| 01/22/2003 | CN1392878A Method of purifying calcium ion-binding protein |
| 01/22/2003 | CN1392798A Mimetic peptides for epitope of apolipoprotein B-100, concatemer and modified peptides, and vaccine composition comprising same |
| 01/22/2003 | CN1392772A Animal showing schizophrenia-like abnormality in coagnitive behaviors and method of construction same |
| 01/22/2003 | CN1099462C Medical composition |
| 01/22/2003 | CN1099423C Human neuropeptide receptor |
| 01/21/2003 | WO2004009834A2 Novel nucleic acids and secreted polypeptides |
| 01/21/2003 | US6509515 Transgenic mice expressing mutant human APP and forming congo red staining plaques |
| 01/21/2003 | US6509514 Chimeric animal model susceptible to human hepatitis C virus infection |
| 01/21/2003 | US6509458 Gene expressed in prostate cancer |
| 01/21/2003 | US6509457 Compositions and methods for modulating apoptosis |
| 01/21/2003 | US6509453 Use of oil bodies and their associated proteins as affinity matrices for the separation and purification of target molecules from samples |
| 01/21/2003 | US6509452 Solubilizing the recombinant bacteria with a surfactant or permeabilizing agent which separates native cell proteins from cell membrane without separating the recombinant protein from the cell, wherein the inclusion bodies remain intact |
| 01/21/2003 | US6509450 Immunoassay for quantification of C-terminal telopeptides of type I collagen in human serum |
| 01/21/2003 | US6509449 To provide a detection method for assaying the polypeptide using the monoclonal antibody |
| 01/21/2003 | US6509448 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/21/2003 | US6509447 G protein chimeras and methods of screening compounds |
| 01/21/2003 | US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production |
| 01/21/2003 | US6509445 Effective metastasis inhibitory actions based on combined properties of two proteins; cancerous metastasis inhibitor with lower toxicity |
| 01/21/2003 | US6509444 Serum amyloid a isoform from colostrum |
| 01/21/2003 | US6509443 Amino acid residue located at position 63 of native-sequence human Insulin like Growth Factor-I is replaced with an alanine residue or amino acid residues at positions 1 and 70 are replaced with serine and valine respectively |
| 01/21/2003 | US6509442 Novel mutations which are associated with aberrant iron metabolism, absorption, or storage, or in advanced cases, clinical hemochromatosis |
| 01/21/2003 | US6509318 TGF-B inhibitors and methods |
| 01/21/2003 | US6509317 Administering a therapeutically effective amount of a bactericidal/permeability-increasing (BPI) protein product to patient exhibiting elevated levels of lipopolysaccharides |
| 01/21/2003 | US6509316 Administering therapeutically effective amount of inhibitor of phospholipase A2 to animal |
| 01/21/2003 | US6509314 Methods of preventing or reducing scarring with decorin or biglycan |
| 01/21/2003 | US6509191 Nucleotide sequences coding plant polypeptide; for use in the generation of transgenic plants of preferential phenotypes |
| 01/21/2003 | US6509189 Nucleic acid molecules encoding the cytoplasmic domain of human Ob receptor |
| 01/21/2003 | US6509174 Cells, genetically modified with optical marker |
| 01/21/2003 | US6509173 Related members of a broad class of polypeptide mediators, which includes the interferons, interleukins and growth factors, collectively called cytokines |
| 01/21/2003 | US6509172 Isolated, truncated nucleic acid which are members of the gage, and uses thereof |
| 01/21/2003 | US6509165 Detecting the ability of proinsulin peptide to preferentially stimulate the T-cells of diabetic subjects by measuring the ability of the T-cells to proliferate or ability of the T-cells to produce cytokines |
| 01/21/2003 | US6509163 Methods of screening modulators of mammalian P2X7 purinergic receptors |
| 01/21/2003 | US6509155 Characterization, diagnosis, prevention, and treatment of cell signaling, immune, and cell proliferative disorders, particularly colon cancer |
| 01/21/2003 | US6509152 Immunosuppressant target proteins |
| 01/21/2003 | US6509151 DNA molecule encoding a Mycobacterium protein and conferring on Mycobacterium tuberculosis an ability to enter mammalian cells and to survive within macrophages |
| 01/21/2003 | US6509033 Immunomodulatory peptides |
| 01/21/2003 | US6509026 Osteopontin coated surfaces and methods of use |
| 01/21/2003 | US6509019 Immunologically active proteins from Borrelia burgdorferi |
| 01/21/2003 | US6509018 Expressed peptides, in particular a strain designated YBF30; including V3 loop region and corresponding nucleotide sequences |
| 01/21/2003 | US6509017 Vaccines containing nucleic acid fragments encoding antigenic proteins that increase resistance to infection; isolated, purified polypeptide having amino acid sequence 1-598 of seq id no: 6 or 1-600 of seq id no: 8 |
| 01/21/2003 | US6509016 Delaying recurrence of ganglioside 2 associated tumors; antibody comprising the light and heavy chain variable region sequences contained in seq id no: 2 and 4 |
| 01/21/2003 | US6509001 Calcitonin receptor binding reagents |
| 01/21/2003 | CA2453344A1 Novel nucleic acids and secreted polypeptides |
| 01/21/2003 | CA2234071C Intensive homologous promoter obtained from hamsters |
| 01/21/2003 | CA2204253C Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 01/21/2003 | CA2096529C Recombinant avirulent salmonella antifertility vaccines |
| 01/21/2003 | CA1341417C Hirudine-expressing vectors, altered cells, and a process for hirudine preparation |
| 01/21/2003 | CA1341416C Hirudine variants, their use and preparation process |
| 01/18/2003 | CA2352702A1 Novel human proton gated ion channel |
| 01/17/2003 | CA2407295A1 Transgenic non-human mammal |
| 01/17/2003 | CA2352439A1 Engineering oncolytic viruses |
| 01/16/2003 | WO2003005636A1 Secure header information for multi-content e-mail |
| 01/16/2003 | WO2003005036A2 Epf receptor assays, compounds and therapeutic compositions |
| 01/16/2003 | WO2003005033A2 Carcinoma-related peptides |
| 01/16/2003 | WO2003005024A1 Use of disease-associated gene |
| 01/16/2003 | WO2003004992A2 Mammalian sweet and amino acid heterodimeric taste receptors |
| 01/16/2003 | WO2003004706A1 Glucocorticoid-induced receptor and methods of use |
| 01/16/2003 | WO2003004704A2 Method of selecting dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity |
| 01/16/2003 | WO2003004701A2 Method for determining the capacity of fusarium in producing trichothecene toxins |
| 01/16/2003 | WO2003004691A2 Regulators of biofilm formation and uses thereof |
| 01/16/2003 | WO2003004689A2 Regulators of biofilm formation and uses thereof |
| 01/16/2003 | WO2003004687A2 Novel proteins and nucleic acids encoding same |
| 01/16/2003 | WO2003004685A2 Soluble steroidal peptides for nucleic acid delivery |
| 01/16/2003 | WO2003004684A2 NUCLEIC ACIDS ENCODING A RECOMBINANT 250 kDa ANTIGEN FROM SPOROZOITES/MEROZOITES OF EIMERIA MAXIMA AND THEIR USES |
| 01/16/2003 | WO2003004683A2 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 01/16/2003 | WO2003004680A2 Atherosclerosis susceptibility gene locus 1 (athsq1) and 2 (athsq2) |
| 01/16/2003 | WO2003004678A2 Novel receptors |
| 01/16/2003 | WO2003004676A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/16/2003 | WO2003004657A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | WO2003004655A2 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences |
| 01/16/2003 | WO2003004651A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | WO2003004650A2 Group b streptococcus antigens and corresponding dna fragments |
| 01/16/2003 | WO2003004646A2 Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors |
| 01/16/2003 | WO2003004643A2 Reversed mammalian protein-protein interaction trap |